Interventions for managing medication‐related osteonecrosis of the jaw
NH Beth-Tasdogan, B Mayer… - Cochrane Database …, 2022 - cochranelibrary.com
Background Medication‐related osteonecrosis of the jaw (MRONJ) is a severe adverse
reaction experienced by some individuals to certain medicines commonly used in the …
reaction experienced by some individuals to certain medicines commonly used in the …
[HTML][HTML] Adjuvant therapies for MRONJ: A systematic review
D Govaerts, F Piccart, A Ockerman, R Coropciuc… - Bone, 2020 - Elsevier
Objective Medication-related osteonecrosis of the jaw (MRONJ) is a severe adverse reaction
caused by the use of antiresorptive antiangiogenic medication. Treating MRONJ is difficult …
caused by the use of antiresorptive antiangiogenic medication. Treating MRONJ is difficult …
[图书][B] Raccomandazioni clinico-terapeutiche sull'osteonecrosi delle ossa mascellari (ONJ) farmaco-relata e sua prevenzione
Il trattamento di ONJ è, dalla sua comparsa in letteratura, argomento molto dibattuto, prima,
come osteonecrosi delle ossa mascellari (BRONJ) associata a bisfosfonati (BP) …
come osteonecrosi delle ossa mascellari (BRONJ) associata a bisfosfonati (BP) …
Efficacy of fibrin-rich platelets and leukocytes (L-PRF) in tissue repair in surgical oral procedures in patients using zoledronic acid—case–control study
Introduction Medication-related osteonecrosis of the jaws (MRONJ) is a complication that
develops in patients who use or have used antiresorptive or antiangiogenic medications for …
develops in patients who use or have used antiresorptive or antiangiogenic medications for …
[HTML][HTML] Leukocyte and platelet rich fibrin in the management of medication-related osteonecrosis of the jaw: A systematic review and meta-analysis
A Muñoz-Salgado, FFV e Silva… - … oral, patologia oral y …, 2023 - ncbi.nlm.nih.gov
Background Osteonecrosis of the jaw (ONJ) has a frequent adverse effect after the
administration of nitrogenous bisphosphonates, as non-nitrogenous bisphosphonates are …
administration of nitrogenous bisphosphonates, as non-nitrogenous bisphosphonates are …
[HTML][HTML] Comparison of the Effectiveness of Conservative and Surgical Treatment of Medication-Related Osteonecrosis of the Jaw: a Systematic Review
R Seluki, M Seluki, I Vaitkeviciene… - Journal of Oral & …, 2023 - ncbi.nlm.nih.gov
Comparison of the Effectiveness of Conservative and Surgical Treatment of Medication-Related
Osteonecrosis of the Jaw: a Systematic Review - PMC Back to Top Skip to main content NIH …
Osteonecrosis of the Jaw: a Systematic Review - PMC Back to Top Skip to main content NIH …
Use of leukocyte-rich and platelet-rich fibrin (L-PRF) adjunct to surgical debridement in the treatment of stage 2 and 3 medication-related osteonecrosis of the jaw
GM Yalcin-Ülker, G Duygu, G Tanan… - Journal of …, 2023 - journals.lww.com
Medication-related osteonecrosis of the jaw (MRONJ) is characterized by exposed necrotic
bone persisting for more than 8 weeks in the maxillofacial region in patients using …
bone persisting for more than 8 weeks in the maxillofacial region in patients using …
The effectiveness of autologous platelet concentrates in prevention and treatment of medication-related osteonecrosis of the jaws: A systematic review
R Sacco, F Mitchell, V Patel… - Journal of Cranio …, 2024 - Elsevier
Medication-related osteonecrosis of the jaw (MRONJ) is a disease caused by adverse
effects of antiresorptive drugs (ARDs) and antiangiogenic drugs (AADs) commonly used in …
effects of antiresorptive drugs (ARDs) and antiangiogenic drugs (AADs) commonly used in …
The preventive effect of photocrosslinked Hep/GelMA hydrogel loaded with PRF on MRONJ
L Tao, Y Gao, Y Li, L Yang, J Yao, H Huang, J Yu… - BMC Oral Health, 2024 - Springer
Background Medication-related osteonecrosis of the Jaw (MRONJ) is a rare but severe side
effect in patients treated with medications such as Bisphosphonates (BPs). Its …
effect in patients treated with medications such as Bisphosphonates (BPs). Its …
Examination of certain single-nucleotide polymorphisms of interleukins 1A and 1B in medication-related osteonecrosis of the jaw—An ambirectional cohort study
S Szentpeteri, J Kosa, HD Juhasz, G Deak… - Journal of Cranio …, 2024 - Elsevier
Aim The aim of this study was to examine particular single-nucleotide polymorphisms (IL-1A-
889 C/T—rs1800587, IL-1B+ 3953 C/T—rs 1143634) of interleukins 1A and 1B in the …
889 C/T—rs1800587, IL-1B+ 3953 C/T—rs 1143634) of interleukins 1A and 1B in the …